Hematology/Oncology Education and CME

Select a Specialty

Ace the Case: A 54-Year-Old Man With Intermittent, Painless Hematuria for the Past 4 Weeks
CMEABIM MOC

Ace the Case: A 54-Year-Old Man With Intermittent, Painless Hematuria for the Past 4 Weeks

There is no commercial support for this activity.

Expiration Date: 11/14/2018
Credit Type(s): CME / ABIM/CME | Credit: 0.25

This “Ace the Case” study will discuss the treatment of a 54-year-old man who presents with intermittent, painless hematuria for the past 4 weeks. Accurately…

go to activity »
Ace the Case: A 48-Year-Old Female Diagnosed With Polycythemia Vera (PV) 7 Years Ago
CMEABIM MOC

Ace the Case: A 48-Year-Old Female Diagnosed With Polycythemia Vera (PV) 7 Years Ago

There is no commercial support for this activity.

Expiration Date: 10/25/2018
Credit Type(s): CME / ABIM/MOC | Credit: 0.25

This “Ace the Case” study will utilize a case study to discuss the treatment of 48-year-old female who was diagnosed with polycythemia vera (PV) 7 years ago. Accurately…

go to activity »
Expert Insights: Genomic Testing for the Extended Endocrine Therapy Dilemma in ER+ Breast Cancer
VIDEO

Expert Insights: Genomic Testing for the Extended Endocrine Therapy Dilemma in ER+ Breast Cancer

This activity is produced by SLACK Incorporated and sponsored by Biotheranostics. Participating physicians are paid consultants of Biotheranostics.

October 24, 2017
Credit Type(s): | Credit: 0

Extending the duration of endocrine therapy beyond 5 years in women with early-stage, estrogen receptor–positive (ER+) breast cancer has been shown in several clinical…

go to activity »
Lymphoma Central: Seeking Cures, Finding Hope

Lymphoma Central: Seeking Cures, Finding Hope

October 11, 2017
Credit Type(s): | Credit: 0

Lymphoma Central is here, your hub for treatment breakthroughs, clinical trial news and expert analysis….

go to activity »
Expert Update: What's New in Essential Thrombocythemia
CME

Expert Update: What's New in Essential Thrombocythemia

This activity is supported by an educational grant from Incyte Corporation.

Expiration Date: 8/22/2018
Credit Type(s): CME | Credit: 0.5

Appropriate early diagnosis and initiation of therapy is essential in the management of myeloproliferative neoplasms (MPNs) to enhance clinical outcomes and patient…

go to activity »
Immune Checkpoint Inhibitors for Advanced Melanoma: Clinical Updates and Multidisciplinary Strategies
CME

Immune Checkpoint Inhibitors for Advanced Melanoma: Clinical Updates and Multidisciplinary Strategies

This activity is supported by an educational grant from Bristol-Myers Squibb.

Expiration Date: 4/27/2018
Credit Type(s): CME | Credit: 1

Incidence rates of melanoma in the United States continue to rise, with an estimated 87,110 new cases being diagnosed in 2017. The early detection of melanoma is…

go to activity »
Liver Cancer Awareness
VIDEO

Liver Cancer Awareness

November 6, 2017
Credit Type(s): | Credit: 0

John P. Roberts, MD, professor of surgery and Chief of the University of California – San Francisco Transplant Service, discusses topics such as the epidemiology of…

go to activity »
Lung Cancer Awareness
VIDEO

Lung Cancer Awareness

October 26, 2017
Credit Type(s): | Credit: 0

Eric Bernicker, MD offers his expert perspective on targeted therapies, immunology, maintenance therapies, and managing patients with progressive and nonprogressive…

go to activity »
Expert Perspectives: The Latest Evidence Regarding Immune Checkpoint Inhibitors for Advanced Bladder Cancer
CME

Expert Perspectives: The Latest Evidence Regarding Immune Checkpoint Inhibitors for Advanced Bladder Cancer

This activity is supported by an educational grant from Merck & Co., Inc.

Expiration Date: 11/15/2018
Credit Type(s): CME | Credit: 1

In 2016, the first immune checkpoint inhibitor was approved by the US Food and Drug Administration (FDA) for the second-line treatment of patients with locally advanced…

go to activity »
Meeting Rewind Video Highlights from HemOnc Today Melanoma
VIDEO

Meeting Rewind Video Highlights from HemOnc Today Melanoma

August 31, 2017
Credit Type(s): | Credit: 0

Select video presentations from HemOnc Today Melanoma include topics such as melanoma pathways and targeted therapeutics….

go to activity »
Patient counseling lessons from three sarcoma experts

Patient counseling lessons from three sarcoma experts

May 1, 2017
Credit Type(s): | Credit: 0

Read what three clinicians have to say about the current state of sarcoma treatment options….

go to activity »
What's Hot in Melanoma? Highlights from the HemONC Today Melanoma and Cutaneous Malignancies 2017 Meeting
CME

What's Hot in Melanoma? Highlights from the HemONC Today Melanoma and Cutaneous Malignancies 2017 Meeting

This activity is supported by an educational grant from Merck & Co, Inc.

Expiration Date: 4/10/2018
Credit Type(s): CME | Credit: 0.5

The development and integration of targeted therapies, as well as immunotherapies, into clinical strategies for the management of advanced melanoma has revolutionized…

go to activity »